Tejnaksh Healthcare Limited Submits Q3FY26 Unaudited Financial Results

3 min read     Updated on 07 Feb 2026, 06:12 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Tejnaksh Healthcare Limited has submitted its Q3FY26 unaudited financial results under Regulation 33, showing consolidated revenue of ₹261.62 lakhs and net profit of ₹28.82 lakhs, both declining from the previous year. The company operates in medical and healthcare services with results approved by the Board on February 07, 2026.

32013744

*this image is generated using AI for illustrative purposes only.

Tejnaksh Healthcare Limited has submitted its unaudited financial results for the quarter and nine months ended December 31, 2025, under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's Board of Directors approved both consolidated and standalone results at their meeting held on February 07, 2026, following review and recommendation by the Audit Committee.

Consolidated Financial Performance

The company's consolidated operations showed mixed performance during the quarter. Revenue from operations declined to ₹261.62 lakhs in Q3FY26 compared to ₹318.98 lakhs in the corresponding quarter of the previous year.

Metric: Q3FY26 Q3FY25 Nine Months FY26 Nine Months FY25
Revenue from Operations: ₹261.62 lakhs ₹318.98 lakhs ₹823.40 lakhs ₹968.22 lakhs
Total Income: ₹268.64 lakhs ₹336.40 lakhs ₹849.07 lakhs ₹1,001.44 lakhs
Net Profit: ₹28.82 lakhs ₹55.54 lakhs ₹83.24 lakhs ₹180.72 lakhs
Basic EPS: ₹0.14 ₹0.38 ₹0.41 ₹0.90

For the nine-month period, consolidated revenue from operations was ₹823.40 lakhs compared to ₹968.22 lakhs in the previous year. Net profit for the nine months stood at ₹83.24 lakhs against ₹180.72 lakhs in the corresponding period last year.

Standalone Financial Results

On a standalone basis, the company reported revenue from operations of ₹169.08 lakhs for Q3FY26, down from ₹223.82 lakhs in Q3FY25. Net profit on standalone basis was ₹22.78 lakhs compared to ₹71.94 lakhs in the previous year quarter.

Parameter: Q3FY26 Standalone Q3FY25 Standalone Nine Months FY26 Nine Months FY25
Revenue from Operations: ₹169.08 lakhs ₹223.82 lakhs ₹540.66 lakhs ₹639.35 lakhs
Total Income: ₹175.05 lakhs ₹237.74 lakhs ₹563.28 lakhs ₹668.38 lakhs
Net Profit: ₹22.78 lakhs ₹71.94 lakhs ₹87.56 lakhs ₹186.61 lakhs
Basic EPS: ₹0.11 ₹0.36 ₹0.43 ₹0.92

For the nine-month standalone period, revenue from operations was ₹540.66 lakhs versus ₹639.35 lakhs in the previous year, while net profit stood at ₹87.56 lakhs compared to ₹186.61 lakhs.

Operational Highlights

The company operates primarily in the medical and healthcare services segment. Key expense categories during Q3FY26 included employee benefits expense of ₹33.41 lakhs on consolidated basis and ₹17.98 lakhs on standalone basis. Other expenses constituted a significant portion at ₹134.49 lakhs for consolidated operations.

Expense Category: Consolidated Q3FY26 Standalone Q3FY26
Employee Benefits: ₹33.41 lakhs ₹17.98 lakhs
Other Expenses: ₹134.49 lakhs ₹70.02 lakhs
Depreciation & Amortization: ₹36.39 lakhs ₹32.51 lakhs
Finance Costs: ₹3.89 lakhs ₹3.89 lakhs

The company maintained its paid-up equity share capital at ₹1,015.68 lakhs with a face value of ₹5 per share.

Regulatory Compliance and Audit

The financial results were prepared in accordance with Indian Accounting Standards (Ind AS) and comply with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The statutory auditors, Maheshwari & Co., conducted a limited review of both consolidated and standalone results without any modifications to their review reports.

The company noted that the Government of India's consolidation of 29 existing labour legislations into four unified labour codes on November 21, 2025, had no material impact on employee benefit expenses for the reporting period. The results include the parent company Tejnaksh Healthcare Limited and its subsidiary Tej Vedaant Healthcare Private Limited.

Historical Stock Returns for Tejnaksh Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+0.65%+0.29%+3.02%-23.50%-39.39%-80.17%
1 Year Returns:-39.39%